Asembia Coverage Highlights SPT Week in Review
5. Data: Helping Define Value-Based Care
Why health system specialty pharmacies are uniquely positioned to provide valuable data and superior care to the patients they serve. Read more.
4. Oncology Innovation Fueling Rapid Pipeline Growth
The oncology drug pipeline has experienced rapid growth over the past decade, driven by innovation in cell therapies, immunotherapy, and precision medicine, according to a specialty pipeline update presentation at the Asembia Specialty Pharmacy Summit 2019. Read more.
3. Co-pay Accumulator Programs: The Debate Continues
Co-pay accumulator programs are the latest cost management initiative resulting from the constant push and pull between payers, pharmacy benefit managers, and manufacturers to reduce drug spend. Read more.
2. Former FDA Commissioner Scott Gottlieb Talks Agency Innovation
At the Asembia Specialty Pharmacy Summit 2019, Scott Gottlieb, MD, 23rd commissioner of the FDA discussed the agency's role in rewriting the modern rules of new regulatory paradigms for a number of recent advancements in medicine. Read more.
1. Massive Change Could Be Looming for Specialty Pharmacy
During the featured session at Asembia’s Specialty Pharmacy Summit 2019, “Specialty Industry Outlook: What’s Next,” speakers Adam Fein, PhD, CEO of the Drug Channels Institute; Lisa Gill, managing director of J.P. Morgan Securities; and Doug Long, vice president of industry relations at IQVIA, explored the radical changes that could be on the horizon from potential legislation that would dramatically alter the health care industry. Read more.